Seroepidemiologic study of hepatitis C virus infection in a general population from the region of La Rioja, Spain;Infección por el virus de la hepatitis C. Estudio seroepidemiológico en población general de La Rioja

Medicina Clinica

Volumn 107, Issue 9, 1996, Pages 331-335

  Sacristan B ^a   Gastanares M J ^a   Elena, A ^b   Sacristan M ^a   Barcenilla, J ^a   Garcia J C ^a   Yanguela J ^a  

^a Complejo Hospitalario S Millan S ^*  (Spain)

^b U de Epidemiología Clin   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; DISEASE TRANSMISSION; EPIDEMIOLOGY; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTOR; SPAIN; STATISTICAL MODEL; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; FEMALE; HEPATITIS C; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0030596786     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
2. Kuo G, Choo Q-L, Alter JH, Gitnick GL, Redeker AG, Purcell RH et al. An assay for circuling antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-364.
3. Alter JH, Purcell RA, Shih SW, Melpolder JC, Houghton M, Choo Q-L et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1.494-1.500.
4. Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A et al. Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 1991; 114: 277-281.
5. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE et al. Hepatitis C virus infection in post-transfusion hepatitis. Analysis with first and second generation assays. N Engl J Med 1991; 325: 325-329.
6. Esteban JI, González A, Hernández JM, Viladomiu L, Sánchez C, López Talavera JC et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323: 1.107-1.112.
7. Llibre JM, Bartrolí M, Berrocal M, González M. Seroprevalencia del virus de la hepatitis C en adictos a drogas por via parenteral. Med Clin (Barc) 1992; 99: 675-676.
8. Mondelli MU, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A. High prevalence of antibodies to hepatitis C virus in hemodyalisis units using a second generation assay. Nephron 1992; 61; 350-351.
9. Wonke B, Hoffbrand AV, Brown D, Dusheiko G. Antibody to hepatitis C virus in multiply transfused patients with thalassemia major. J Clin Pathol 1990; 43; 638-640.
10. Rumi MG, Colombo M, Gringeri A, Mannucci PM. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminasas. Ann Intern Med 1990; 112: 379-380.
11. Bjoro K, Froland S, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hipogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331: 1.607-1.611.
12. Sánchez Tapias JM, Barrera JM, Costa J, Ercilla MG, Parés A, Bruguera M et al. Hepatitis C virus infection in patients with nonalcoholic chronic liver disease. Ann Intern Med 1990; 112: 921-924.
13. Jeffers LJ, Hasan F, Medina M, Reddy R, Parker T, Silva M et al. Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology 1992; 15: 187-190.
14. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tomassini MA et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1.006-1.008.
15. Vargas V, Castell L, Esteban JI. High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma. Ann Intern Med 1990; 112: 232-233.
16. Salleras L, Bruguera M, Vidal J, Plans P, Domínguez A, Navas E et al. Seroepidemiología de la infección por el virus de la hepatitis C en las mujeres embarazadas de Cataluña. Med Clin (Barc) 1994; 103: 721-724.
17. Fernández Rodriguez E, Velasco FL, Riestra S, Gárate F, García Alonso S, Ocio G. Prevalencia de la infección por el virus de la hepatitis C en gestantes. Clin Ginecol Obstet 1993; 20: 142-147.
18. Hoffman H, Kunz C. How risk of health care workers for infection with hepatitis C virus. Infection 1990; 18: 286-288.
19. Villate JI, Corral J, Aguirre C, Carandi B, Cobo M, Urcelay I et al. Anticuerpos frente al virus de la hepatitis C en el personal hospitalario. Med Clin (Barc) 1993; 100: 766-769.
20. Germanaud J, Barthez JP, Causse X. The occupational risk of hepatitis C infection among hospital employees. Am J Public Health 1994; 84: 122.
21. Janot C, Couroucé AM, Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet 1989; 2: 796-797.
22. Martin AM, Canut A, Corral M, Cordero M. Seroprevalencia del virus de la hepatitis C en donantes y grupos de alto y bajo riesgo de Salamanca. Med Clin (Barc) 1992; 98: 676-677.
23. Pastor JM, Hermosa V, Ruiz Tagle MA, Zubizarreta A. Anticuerpos anti-VHC en donantes de sangre en Cantabria. Incidencia y relación con niveles de transaminasas. Sangre 1990; 35: 205-207.
24. Suárez A, Rodriguez M, Riestra S, Navascués CA, San Román FS, Otero L et al. Prevalencia de la positividad del anti-VHC entre donantes de sangre en Asturias. Un estudio clinicoepidemiológico. Med Clin (Barc) 1994; 103: 606-610.
25. Heinzelman EJ, Naseer K, Gopal A, Howden CW, Vasudeva R. Seroprevalence of markers for hepatitis B virus (HBV) and hepatitis C virus (HCV) in a community-based mass screening program. Am J Gastroenterol 1993; 88: 1.550.
26. Mata M, Sesma P, Diaz M, Pena S, Bernárdez I. Anticuerpos frente al virus de la hepatitis C en la población de El Ferrol. Gastroenterol Hepatol 1993; 16: 461.
27. Merican I, Sherlock S, McIntyre N, Dusheiko GM. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q J Med 1993; 86: 119-125.
28. De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 1994; 20: 1.225-1.230.
29. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoffnagle JH, Melpolder JJ, Alter HJ. Long-term clinical histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969-974.
30. Dhillon AP, Dusheiko GM. Pathology of hepatitis C virus infection. Histopathology 1995; 26: 297-309.
31. Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994; 19: 222-226.
32. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240-243.
33. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1.797-1.801.
34. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K et al. A multivariate analysis of factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
35. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994; 35: 828-832.
36. Harlé JR, Disdier P, Dussol B, Bolla G, Casanova P, Weiller PJ. Membranoproliferative glomerulonephritis and C infection. Lancet 1993; 341: 904.
37. Pawlotsky JM, Yahia MB, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-848.
38. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidai J et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 341: 788-789.
39. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C et al. Prevalence of chronic liver disease in the general population of Northerm Italy: The Dionysos Study. Hepatology 1994; 20: 1.442-1.449.
40. Bruguera M, La hepatitis C, otra plaga. Med Clin (Barc) 1994; 103: 615-616.
41. García-Bengoechea M, Emparanza J, Sarriugarte A, Cortés A, Vega JL, González F et al. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroent Hepatol 1995; 7: 237-241.
42. Andreu J, Abad MA, Sánchez-Quijano A, Torronteras R, Luque F, García de las Heras J et al. High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. J Intern Med 1994; 236: 73-77.
43. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15: 5-14.
44. Serfaty L, Giral P, Elghouzzi MH, Jullien AM, Poupon R. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to Riba-2 status. A case-control survey. Hepatology 1993; 17: 183-187.
45. Esteban JI, López-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muñiz E et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443-449.
46. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors. The role of parenteral and sexual transmission. Scand J Infect Dis 1995; 27: 99-104.
47. Donauhe JG, Muñoz A, Ness P, Brown DE, Yawn DH, McAllister HA et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373.
48. Ko Y, Ho MS, Chiang TA, Chang SJ, Chan PY. Tattoing as a risk of hepatitis C virus infection. J Med Virol 1992; 38: 288-291.
49. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2.231-2.235.
50. Kelen GD, Green GB, Purcell RH, Chan DW, Qaqish BF, Siverston KJ et al. Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 1992; 326: 1.399-1.404.
51. Alter MJ. Inapparent transmission of hepatitis C: footprints in the sand. Hepatology 1991; 14: 389-391.
52. D'Amelio R, Stroffolini T, Matricardi PM, Nisini N, Tosti ME, Trematerra M et al. Low prevalence of anti-HCV antibodies among Italian Air Forces recruits. Scand J Infect Dis 1995; 27: 12-14.
53. Mattsson L, Aberg B, Von Sydow M, Weiland O. Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in Sweden. Scand J Infect Dis 1991; 23: 25-29.
54. Silverman AL, Puccio JE, Kulesza GW, McCray DG, Gordon SC. HCV-RNA is present in the menstrual blood of women with chronic hepatitis C infection. Am J Gastroentetol 1994; 89: 1.201-1.202.
55. Wu JC, Lin HC, Jeng FS, Ma GY, Lee SD, Sheng WY. Prevalence, infectivity and risk factor analysis of hepatitis C virus infection in prostitutes. J Med Virol 1993; 39: 312-317.
56. Dominguez A, Vidai J, Bruguera M, Salleras L. Prevalencia de anticuerpos frente al virus de la hepatitis C en varones homosexuales. Med Clin (Barc) 1994; 102: 478-479.
57. Soto B, Rodrigo L, García-Bengoechea M, Sánchez-Quijano A, Riestra S, Arenas JI et al. Heterosexual Transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus in the index case. A multicenter study of 423 pairings. J Intern Med 1994; 326: 515-519.
58. Akahane Y, Kojima M, Sugai Y, Sakamoto M, Miyazaki Y, Tanaka T et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994; 120: 748-752.
59. Diago M, Zapater R, Tuset C, González C, Cors R, Carbonell P et al. Improbable transmisión intrafamiliar del virus de la hepatitis C. Gastroenterol Hepatol 1995; 18: 224.
60. Casarin C, Diodati G, Bonetti P, Tagger A, Ribero ML, Ruol A et al. Possible intrafamilial spread of HCV infection from patients with chronic hepatitis C. J Hepatol 1994; 21 (Supl 1): 33.
61. Sagnelli GB, Gaeta FM, Felaco T, Stroffolini A, Andriulli F, Bonino M et al. Household diffusion of HCV infection: a multicenter case-control study. J Hepatol 1994; 21 (Supl 1): 65.
62. Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 344: 1.475-1.479.
63. Ohto H, Terazawa S, Sasaki N, Hino K, Ishiwata Ch et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330: 774-750.
64. Alter MJ. Transmission of hepatitis C virus, route, dose and titer. N Engl J Med 1994; 330: 784-785.